Publications by authors named "Caroline Fortier"

Claim this Profile
A
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.
Brandon M Huffman, Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S Kapner, Caroline Fortier

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi Syndrome.
Jennifer L Miller, André Lacroix, Lynne M Bird, Ashley H Shoemaker, Andrea Haqq, Caroline Fortier

J Clin Endocrinol Metab· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors.
Quincy Siu-Chung Chu, Nathaniel Bouganim, Caroline Fortier, Sara Zaknoen, John R Stille

Invest New Drugs· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Calcium Release-activated Calcium Channel Is Not Sufficient to Prevent Rejection in Nonhuman Primate Kidney Transplantation.
Jean Kwun, Brian Ezekian, Miriam Manook, Jaeberm Park, Janghoon Yoon, Caroline Fortier

Transplantation· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking the Sugar Rush: Incorporating Continuous Glucose Monitoring Into Multisite Early Clinical Research With Type 2 Diabetes Subjects.
Sabina Paglialunga, Bruce H Morimoto, Amparo de la Peña, Caroline Fortier

Clin Pharmacol Drug Dev· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis